These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5855864)

  • 1. [The composition of rifamycin B and related rifamycins].
    Oppolzer W; Prelog V; Sensi P
    Experientia; 1964 Jun; 20(6):336-9. PubMed ID: 5855864
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel degradation of rifamycin: isolation of the new ansa chain derivative from rifampicin.
    Kinoshita M; Tatsuta K; Nakata M
    J Antibiot (Tokyo); 1978 Jun; 31(6):630-1. PubMed ID: 681247
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifamycins. XLI. A new class of active semisynthetic rifamycins. N-substituted aminomethyl derivatives of rifamycin SV 2.
    Maggi N; Arioli V; Sensi P
    J Med Chem; 1965 Nov; 8(6):790-3. PubMed ID: 5885073
    [No Abstract]   [Full Text] [Related]  

  • 4. History of the development of rifampin.
    Sensi P
    Rev Infect Dis; 1983; 5 Suppl 3():S402-6. PubMed ID: 6635432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatographic-mass spectrometric studies on rifamycin antibiotics.
    Vékey K; Edwards DM; Zerilli LF
    J Chromatogr; 1989 Jul; 474(1):317-27. PubMed ID: 2768398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifamycin Derivatives Are Effective Against Staphylococcal Biofilms In Vitro and Elutable From PMMA.
    Sanchez CJ; Shiels SM; Tennent DJ; Hardy SK; Murray CK; Wenke JC
    Clin Orthop Relat Res; 2015 Sep; 473(9):2874-84. PubMed ID: 25896136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus.
    Murphy CK; Mullin S; Osburne MS; van Duzer J; Siedlecki J; Yu X; Kerstein K; Cynamon M; Rothstein DM
    Antimicrob Agents Chemother; 2006 Mar; 50(3):827-34. PubMed ID: 16495239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of a rifamycin derivative (AF-013) which is active on the nucleic acid polymerases insensitive to rifampicin.
    Riva S; Fietta A; Silvestri LG
    Biochem Biophys Res Commun; 1972 Dec; 49(5):1263-71. PubMed ID: 4566674
    [No Abstract]   [Full Text] [Related]  

  • 9. The quantitative structure-activity relationship of rifamycin B amide and hydrazide toxicity in mice.
    Quinn FR
    Farmaco Sci; 1982 Jan; 37(1):3-12. PubMed ID: 7056391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physico-chemical properties of FCE 22250, 3-(piperidinomethylazinomethyl)rifamycin SV, a new long-acting rifamycin.
    Vigevani A; Arlandini E; Ballabio M; Franceschi G; Gioia B; Vioglio S
    Farmaco Prat; 1985 May; 40(5):131-40. PubMed ID: 3839192
    [No Abstract]   [Full Text] [Related]  

  • 11. New derivatives of rifamycin antibiotics.
    Bickel H; Knüsel F; Kump W; Neipp L
    Antimicrob Agents Chemother (Bethesda); 1966; 6():352-8. PubMed ID: 5985257
    [No Abstract]   [Full Text] [Related]  

  • 12. [Physio-chemical considerations on a chromatic phenomenon produced by a mixture of rifamycin S and SV in the free acid state].
    Curci G; Sarluca F
    G Ital Chemioter; 1966; 13(1):27-31. PubMed ID: 5994447
    [No Abstract]   [Full Text] [Related]  

  • 13. The x-ray analysis of the structure of rifamycin Y.
    Brufani M; Fedeli W; Giacomello G; Vaciago A
    Experientia; 1967 Jul; 23(7):508-12. PubMed ID: 6057726
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus isolates in murine models of infection.
    Rothstein DM; Farquhar RS; Sirokman K; Sondergaard KL; Hazlett C; Doye AA; Gwathmey JK; Mullin S; van Duzer J; Murphy CK
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3658-64. PubMed ID: 16940074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electron spin resonance studies on the oxidation of rifamycin SV catalyzed by metal ions.
    Kono Y; Sugiura Y
    J Biochem; 1982 Jan; 91(1):397-401. PubMed ID: 6279586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coordination of the 13C-NMR. spectrum of rifamycin S on the basis of selective uncoupling of protons].
    Fuhrer H
    Helv Chim Acta; 1973 Jul; 56(7):2377-86. PubMed ID: 4761276
    [No Abstract]   [Full Text] [Related]  

  • 17. [Understanding of rifamycin S. Reactions of the ansa-rings. Modifications of antibiotics. 8].
    Kump W; Bickel H
    Helv Chim Acta; 1973 Jul; 56(7):2323-47. PubMed ID: 4761274
    [No Abstract]   [Full Text] [Related]  

  • 18. New rifamycins. II. Synthesis and biological activity of oximes, hydrazones, and semicarbazones of 3-N-(piperidin-4-one)rifamycin S.
    Marsili L; Franceschi G; Galliani C; Sanfilippo A; Vigevani A
    Farmaco Sci; 1982 Dec; 37(12):781-6. PubMed ID: 7152013
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the configuration of rifamycin B and related rifamycins].
    Leitich J; Oppolzer W; Prelog V
    Experientia; 1964 Jun; 20(6):343-4. PubMed ID: 5855866
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rifamycin].
    Acocella G
    G Ital Chemioter; 1983; 30(1):1-24. PubMed ID: 6363192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.